Spyre Therapeutics, Inc. (SYRE)

93.19 +3.26 (+3.62%) USD  |  NASDAQ  |  Oct 02, 16:00
93.19 0.00 (0.00%) Pre-Market: 20:00
More

Spyre Therapeutics EV to EBIT

EV to EBIT Chart

View EV to EBIT for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to EBIT Data

View and export this data back to . Start Trial.
Date Value

EV to EBIT Range, Past 5 Years

View EV to EBIT Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBIT Benchmarks

View EV to EBIT Benchmarks
Start Trial
AbbVie, Inc. Upgrade
Incyte Corp. Upgrade
SELLAS Life Sciences Group, Inc. --
Relay Therapeutics, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade

EV to EBIT Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade